封面
市场调查报告书
商品编码
1186669

影像诱导治疗系统市场:现状分析及预测(2022年~2028年)

Image Guided Therapy System Market: Current Analysis and Forecast (2022-2028)

出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 162 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球影像诱导治疗系统的市场规模在预测期间内预计将以约6%的显着成长率扩大。影像诱导治疗系统,是癌症的放射治疗的措施的增加,慢性病患的负担增加,老年人口的增加等,各种各样的要素扩大着。

本报告提供全球影像诱导治疗系统市场相关调查,提供市场概要,以及各产品类型,各用途,各终端用户,各地区的趋势,及加入此市场的主要企业简介等资讯。

目录

第1章 市场简介

第2章 调查方法或假设

第3章 市场摘要

第4章 摘要整理

第5章 COVID-19对影像诱导治疗系统市场带来的影响

第6章 影像诱导治疗系统市场收益,2020年~2028年

第7章 各产品类型的市场洞察

  • 超音波设备
  • 电脑断层摄影(CT)扫描机
  • 核磁共振影像(MRI)
  • 内视镜
  • 正子放出断层摄影法(PET)
  • 其他

第8章 各用途的市场洞察

  • 脑神经外科
  • 心血管手术
  • 泌尿科
  • 整形外科
  • 其他

第9章 各终端用户的市场洞察

  • 医院
  • 门诊病人手术中心
  • 诊疗所

第10章 各地区的市场洞察

  • 北美
  • 欧洲
  • 亚太地区
  • 其他地区

第11章 影像诱导治疗系统市场市场动态

  • 推动市场要素
  • 市场课题
  • 影响分析

第12章 影像诱导治疗系统的市场机会

第13章 影像诱导治疗系统的市场趋势

第14章 需求面和供给方面的分析

第15章 价值链分析

第16章 竞争模式

第17章 企业简介

  • Koninklijke Philips N.V.
  • Medtronic Plc.
  • Siemens Healthineers
  • Analogic Corporation
  • GE Healthcare
  • Varian Medical Systems Inc.
  • Brainlab AG
  • Olympus Corporation
  • Stryker
  • FUJIFILM Holdings Corporation

第18章 免责声明

简介目录
Product Code: UMME211481

The global image guided therapy system market is expected to grow at a significant rate of around 6% during the forecast period. Image-guided therapy interrogates the use of any form of medical imaging to plan, perform, and evaluate surgical procedures and therapeutic interventions. Techniques for image-guided therapy aid in making surgeries less invasive and more precise. The most prevalent methods are Computed Tomography (CT) and Magnetic Resonance Imaging (MRI). These techniques are likewise upheld by ultrasound, angiography, careful route hardware, following devices, and joining programming.

Moreover, the image-guided therapy system is expanding due to a number of factors, including an increase in initiatives for cancer radiotherapy, an increase in the burden of chronic diseases, and an increase in the elderly population. According to the GLOBOCAN 2020 report from the International Agency for Research on Cancer, which estimated the incidence and mortality of 36 cancers in 185 countries worldwide, an estimated 19,292,789 new cases of cancer were diagnosed in 2020 and approximately 9,958,133 people died from cancer worldwide.

Koninklijke Philips N.V., Medtronic Plc., Siemens Healthineers, Analogic Corporation, GE Healthcare, Varian Medical Systems Inc., Brainlab AG, Olympus Corporation, Stryker, FUJIFILM Holdings Corporation Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report:

"Amongst application, cardiac surgery category to witness robust CAGR during the forecast period"

Based on application, the market is segmented into neurosurgery, cardiac surgery, urology, orthopedic surgery, and others. Amongst, the cardiac surgery category is to witness higher CAGR during the forecast period owing to the growing number of chronic diseases such as cardiovascular diseases, cancer, and the rising geriatric populatioN.

Also, during the forecast period, the neurosurgery sector is likely to expand at a profitable rate. This market is primarily driven by the high prevalence of neurological disorders and the rising number of accident and trauma cases.

"Amongst end-user, the hospitals to hold a significant share in the market in 2020"

On the basis of end-user, the market is categorized into hospitals, ambulatory surgery centers, and clinics. Among these, the hospitals to hold a significant share of the market in 2020. This is mainly due to the availability of neurovascular devices, skilled healthcare professionals, and the safety & efficacy during the treatment procedures. Moreover, the growing patient pool suffering from neurovascular diseases such as brain aneurysms, and arteriovenous malformations are also contributing to the growth of this market during the forecast period. For instance, according to the Brain Aneurysms Foundation, about 30,000 people in the United States suffer a brain aneurysm rupture each year.

"North America to hold a significant share in the market"

For a better understanding of the market adoption of the IMAGE GUIDED THERAPY SYSTEM industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period. Due to its well-established healthcare infrastructure, rapid adoption of advanced radiation therapies, and technological advancements. Additionally, the high demand for minimally invasive procedures and value-based reimbursements in this region will boost the growth of the image guided therapy system market due to the region's aging population and rising chronic disease cases. The well-established healthcare sector and the rising incidence of cancer are the primary drivers of the market's expansion in the United States.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

The Global image guided therapy system market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the IMAGE GUIDED THERAPY SYSTEM MARKET
  • 2.2. Research Methodology of the IMAGE GUIDED THERAPY SYSTEM MARKET
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE IMAGE GUIDED THERAPY SYSTEM MARKET

6 IMAGE GUIDED THERAPY SYSTEM MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY PRODUCT TYPE

  • 7.1. Ultrasound Systems
  • 7.2. Computed Tomography (CT) Scanners
  • 7.3. Magnetic Resonance Imaging (MRI)
  • 7.4. Endoscopes
  • 7.5. Positron Emission Tomography (PET)
  • 7.6. Others

8 MARKET INSIGHTS BY APPLICATION

  • 8.1. Neurosurgery
  • 8.2. Cardiac Surgery
  • 8.3. Urology
  • 8.4. Orthopedic Surgery
  • 8.5. Others

9 MARKET INSIGHTS BY END-USER

  • 9.1. Hospitals
  • 9.2. Ambulatory Surgery Centers
  • 9.3. Clinics

10 MARKET INSIGHTS BY REGION

  • 10.1. North America
    • 10.1.1. U.S.
    • 10.1.2. Canada
    • 10.1.3. Rest of North America
  • 10.2. Europe
    • 10.2.1. Germany
    • 10.2.2. U.K.
    • 10.2.3. France
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Rest of Europe
  • 10.3. Asia-Pacific
    • 10.3.1. China
    • 10.3.2. Japan
    • 10.3.3. India
    • 10.3.4. Rest of Asia-Pacific
  • 10.4. Rest of World

11 IMAGE GUIDED THERAPY SYSTEM MARKET DYNAMICS

  • 11.1. Market Drivers
  • 11.2. Market Challenges
  • 11.3. Impact Analysis

12 IMAGE GUIDED THERAPY SYSTEM MARKET OPPORTUNITIES

13 IMAGE GUIDED THERAPY SYSTEM MARKET TRENDS

14 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 14.1. Demand Side Analysis
  • 14.2. Supply Side Analysis

15 VALUE CHAIN ANALYSIS

16 COMPETITIVE SCENARIO

  • 16.1. Competitive Landscape
    • 16.1.1. Porters Fiver Forces Analysis

17 COMPANY PROFILED

  • 17.1. Koninklijke Philips N.V.
  • 17.2. Medtronic Plc.
  • 17.3. Siemens Healthineers
  • 17.4. Analogic Corporation
  • 17.5. GE Healthcare
  • 17.6. Varian Medical Systems Inc.
  • 17.7. Brainlab AG
  • 17.8. Olympus Corporation
  • 17.9. Stryker
  • 17.10. FUJIFILM Holdings Corporation

18 DISCLAIMER